| |
| |
|
| Insider
Information: |
Aryeh Jason |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
401,047 |
|
|
Indirect Shares
|
890,847 |
|
|
| Direct
Value |
$7,198,450 |
|
|
|
Indirect Value
|
$5,034,433 |
|
|
| Total
Shares |
1,291,894 |
|
|
| Total
Value |
$12,232,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-30 |
76,828 |
2024-04-30 |
56,619 |
Premium* |
|
|
Vaxart Inc |
VXRT |
Director |
2010-12-27 |
0 |
2011-03-15 |
131,783 |
Premium* |
|
|
Myrexis Inc |
MYRX |
Director |
|
0 |
2012-06-15 |
552,145 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Director |
2017-05-15 |
242,433 |
2017-05-15 |
150,300 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-23 |
15,000 |
2017-05-23 |
0 |
Premium* |
|
|
Merrimack Pharmaceuticals Inc |
MACK |
See Explanation of Res... |
2019-07-16 |
3,802 |
2019-07-11 |
0 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2023-04-12 |
62,984 |
2023-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
175 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2006-09-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,700 |
|
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2006-09-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,572,668 |
|
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2006-09-27 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
34,150 |
|
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2007-05-30 |
4 |
B |
$6.48 |
$21,708 |
I/I |
3,350 |
12,150 |
2.1 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2007-05-30 |
4 |
B |
$6.48 |
$32,400 |
D/D |
5,000 |
29,700 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2007-05-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
5,000 |
34,700 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2008-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
39,700 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2009-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
44,700 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2009-09-15 |
4 |
A |
$0.00 |
$0 |
I/I |
17,000 |
1,232,650 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2009-11-16 |
4 |
S |
$4.49 |
$1,151,308 |
I/I |
(255,276) |
977,374 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2009-11-17 |
4 |
S |
$4.64 |
$941,934 |
I/I |
(185,909) |
791,465 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2009-12-16 |
4 |
S |
$5.24 |
$21,196 |
I/I |
(4,045) |
787,420 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2009-12-22 |
4 |
S |
$5.24 |
$42,103 |
I/I |
(8,035) |
779,385 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-01-06 |
4 |
AS |
$5.24 |
$222,154 |
I/I |
(42,365) |
737,020 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-01-07 |
4 |
AS |
$5.29 |
$18,213 |
I/I |
(3,443) |
733,577 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-01-08 |
4 |
AS |
$5.29 |
$244,171 |
I/I |
(46,157) |
687,420 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-01-12 |
4 |
AS |
$5.49 |
$473,367 |
I/I |
(86,200) |
601,220 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-01-13 |
4 |
AS |
$5.49 |
$75,774 |
I/I |
(13,800) |
587,420 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-08 |
4 |
AS |
$5.75 |
$18,393 |
I/I |
(3,200) |
584,220 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-10 |
4 |
AS |
$5.74 |
$92,414 |
I/I |
(16,100) |
568,120 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-11 |
4 |
AS |
$5.88 |
$1,062,335 |
I/I |
(180,700) |
387,420 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-12 |
4 |
S |
$5.93 |
$98,374 |
I/I |
(16,600) |
370,820 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-15 |
4 |
S |
$5.93 |
$1,186 |
I/I |
(200) |
370,620 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-17 |
4 |
S |
$5.94 |
$67,881 |
I/I |
(11,419) |
359,201 |
0 |
- |
|
| VXRT |
Vaxart Inc |
Director |
– • – |
2010-03-18 |
4 |
S |
$5.96 |
$39,225 |
I/I |
(6,581) |
352,620 |
0 |
- |
|
175 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
